Compound Semiconductor Patents: Who Leads, Where the Gaps Are 2026
- Filings peaked in 2017 at 29 and fell toward single digits by 2022, with zero completed filings in the most recent tracked year across every leading assignee.
- H01L and C30B carry the bulk of the 625 tracked families, while smaller subclasses like H10N (14) and H10W (17) remain comparatively unclaimed.
- The most-cited record in the corpus is a gallium trichloride delivery system cited 448 times, signalling that precursor delivery, not device architecture, anchors the field's most influential prior art.
A field staked out early, now defended rather than expanded
Compound semiconductor manufacturing — covering III-V wafer processing, MBE growth and selective area growth under IPC classes C30B and H01L — shows a filing pattern typical of a technology whose core process claims were established a decade ago and have not needed major renewal since. The dataset’s 625 patent families peaked in 2017 and have declined toward single digits by the early 2020s, with no completed filings from any tracked assignee in the most recent year.
Claim density concentrates in device-integration filings under H01L and crystal-growth filings under C30B, while smaller subclasses covering other solid-state device types remain comparatively open. The most influential prior art, measured by citation count, sits in precursor-delivery and crystal-formation methods rather than in downstream device architecture — a distinction worth checking before assuming a device-level claim is unencumbered.
Filing trends and technology composition
The dataset spans 625 patent families published between 2015 and mid-2026, filed across six major receiving offices and classified under eight IPC subclasses tied to compound semiconductor growth and device integration.
Filings peaked in 2017 and have not recovered
Annual filings ran from 29 in 2017 to 6 at the 2022 midpoint, with the most recent tracked year showing no completed filings — a pattern consistent with a maturing claim space rather than a growing one, though the last 18 months are understated by publication lag.
H01L and C30B carry the bulk of the claim volume
Semiconductor devices (H01L, 540 records) and crystal growth (C30B, 300 records) dominate the classification spread, followed by a laser and optoelectronics cluster (H01S, 133) and a general semiconductor-device group (H10D, 114); smaller subclasses such as H10N (14) and H10W (17) show comparatively little filing activity.
Shares are the percentage of the 625 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Compound Semiconductor Manufacturing Process with Eureka
This page is one run against one query. Ask Eureka your own question about compound semiconductor manufacturing process and every answer comes back with the patent numbers behind it.
Try EurekaThe most-cited records in this dataset
Method for Manufacturing a Si-Based High-Mobility CMOS Device With Stacked Channel Layers
A device and method for manufacturing a Si-based high-mobility CMOS device is provided. The method includes providing a silicon substrate with a first insulation layer and a trench, manufacturing a III-V semiconductor channel layer above the insulation layer by depositing a sacrificial dummy layer, capping it with oxide, and replacing the dummy material with III-V semiconductor via etched via-holes and selective area growth, then forming a second insulation layer above the channel layer and uncovering the trench.Filed by IMEC VZW on 2017-06-22 under publication number US20170178971A1.
| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US20090223441A1 | High volume delivery system for gallium trichloride | 448 |
| 2 | US5578503A | Rapid process for producing a chalcopyrite semiconductor on a substrate | 339 |
| 3 | US6455398B1 | Silicon on III-V semiconductor bonding for monolithic optoelectronic integration | 248 |
| 4 | US6392257B1 | Semiconductor structure, semiconductor device, communicating device, integrated circuit, and process for fabr… | 168 |
| 5 | US5159413A | Monolithic integrated circuit having compound semiconductor layer epitaxially grown on ceramic substrate | 165 |
| 6 | US6331450B1 | Method of manufacturing semiconductor device using group III nitride compound | 149 |
| 7 | US5620557A | Sapphireless group III nitride semiconductor and method for making same | 143 |
| 8 | US5356831A | Method of making a monolithic integrated circuit having compound semiconductor layer epitaxially grown on cer… | 120 |
| 9 | EP1796180A1 | Light emitting element and its manufacturing method | 116 |
| 10 | US5399522A | Method of growing compound semiconductor | 113 |
Ranked by citation count within this searched corpus; older records accumulate more citations by virtue of age, so treat this as a measure of influence rather than current commercial weight.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the filing pattern signals
Beyond the raw counts, the shape of this dataset points to a field where the core process claims are largely staked out and activity has shifted toward defence and refinement rather than expansion.
Activity has cooled since 2017
Every leading assignee tracked for recent-year momentum, including Sumitomo Electric, Sony, Toshiba and Fujitsu, shows zero filings in the latest year. Combined with a midpoint of 6 filings in 2022, the trajectory is flat to declining rather than accelerating.
Device integration dominates the classification spread
H01L (semiconductor devices) appears in 540 of 625 records, well ahead of C30B crystal growth at 300, indicating that most claims are written at the device-integration level even when the underlying process is a growth technique.
Precursor delivery, not device design, is the most-cited art
The single most-cited record in the corpus covers a gallium trichloride delivery system, ahead of chalcopyrite growth and silicon/III-V bonding records. Influence in this field traces back to enabling process equipment as much as to final device claims.
Collaboration is limited and concentrated
Only ten co-assignee pairs appear across the dataset, with the strongest linking Sony and Sumitomo Electric. Most families are filed by a single assignee, suggesting joint development is the exception rather than the norm in this space.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to compound semiconductor manufacturing process, with the prior art for and against each one.
| Assignee | Co-assignee | Shared families |
|---|---|---|
| Sony Group Corporation | Sumitomo Electric Industries, Ltd. | 11 |
| IMEC (Interuniversity Microelectronics Centre) | Katholieke Universiteit Leuven (KU Leuven) | 6 |
| Soitec | WERKHOVEN CHRISTIAAN | 5 |
| Soitec | ARENA CHANTAL | 5 |
| Soitec | STEIDL THOMAS ANDREW | 2 |
| Soitec | CLARK ROBERT DANIEL | 2 |
| Soitec | BIRTCHER CHARLES MICHAEL | 2 |
| Sony Group Corporation | OOHATA TOYOHARU | 1 |
The strongest co-assignee link pairs Sony with Sumitomo Electric Industries; a second recurring pairing links IMEC with the Catholic University of Leuven, reflecting an academic-industry research relationship rather than a commercial joint venture.
Who holds the ground, and where it is thinning
The assignee ranking is led by established Japanese and European electronics and materials firms with long histories in III-V processing, alongside academic-industry research consortia. Recent-year momentum has flattened across the board, which changes where a new entrant should look for open claim space.
Established filers have gone quiet
Sumitomo Electric Industries, Sony, Toshiba, Fujitsu, Soitec and Motorola all show zero filings in the most recent tracked year, despite being among the historical leaders in this dataset. Their portfolios remain in force but are not being actively expanded.
Academic-industry collaboration is concentrated in one pairing
IMEC VZW and the Catholic University of Leuven form one of the strongest recurring co-assignee links in the dataset, reflecting a sustained research relationship distinct from the largely single-assignee commercial filings elsewhere.
The strongest commercial pairing links two Japanese firms
Sony and Sumitomo Electric Industries co-file more frequently than any other pair in the dataset, suggesting a shared supply or joint-development relationship around III-V material integration.
| Assignee | Recent year | YoY |
|---|---|---|
| Motorola, Inc. | 0 | — |
| Soitec | 0 | — |
| Sony Group Corporation | 0 | — |
| Toshiba Corporation | 0 | — |
| Sumitomo Electric Industries, Ltd. | 0 | — |
| Fujitsu Limited | 0 | — |
| IMEC (Interuniversity Microelectronics Centre) | 0 | — |
| International Business Machines Corporation (IBM) | 0 | — |
Where to take this analysis
The filing data points to a field with settled core claims and a few thinner adjacent branches. The next steps depend on whether the goal is freedom-to-operate, white-space filing, or tracking a specific incumbent.
Map freedom-to-operate against the top-cited records
Start with the gallium trichloride delivery and chalcopyrite growth patents, since they anchor the most-cited claim territory in the corpus and are most likely to surface in a clearance search.
Run a claim search in EurekaTrack incumbent portfolios for expiry and renewal gaps
With every leading assignee showing zero recent-year filings, monitoring expiry dates on their core families may reveal when currently blocked process steps become open to file around.
Set up portfolio monitoring in EurekaEvaluate the under-claimed IPC branches for a first filing
Subclasses like H10N and H10W show materially lower density than H01L or C30B, making them worth a closer technical review before assuming they are already crowded.
Explore white space in EurekaFrequently asked questions
The dataset's assignee ranking is dominated by established electronics and materials firms with long filing histories in III-V and crystal-growth technology, including names such as Sumitomo Electric Industries, Sony, Toshiba, Fujitsu and Soitec, alongside research consortia like IMEC. None of the tracked assignees show filings in the most recent year, which points to a period of consolidation rather than active new claim-staking. Readers evaluating freedom-to-operate should look at each assignee's full family history rather than just recent activity, since older grants often carry the broadest and most-cited claims.
Filings peaked in 2017 at 29 records and had fallen to roughly 6 by the 2022 midpoint, with the most recent year showing no completed filings in this dataset. This flat-to-declining trend should be read with the caveat that publication typically lags filing by about 18 months, so the last one to two years are undercounted. Taken together, the pattern suggests the core process claims were staked out in the mid-2010s and the field has since moved toward incremental refinement rather than a new filing wave.
Molecular beam epitaxy (MBE) growth claims generally cover layer-by-layer deposition of III-V material across a substrate, while selective area growth claims specify deposition confined to defined openings, typically etched through an oxide or dummy layer, as seen in the representative IMEC record covering stacked III-V channel formation. The two are often combined in a single fabrication sequence, and dense IPC overlap between C30B (crystal growth) and H01L (semiconductor devices) reflects that combination. Distinguishing which mechanism a target patent actually claims is important, because broad MBE method claims are harder to design around than a narrow, geometry-specific selective-area-growth step.
The United States leads by a wide margin with 325 records in this dataset, followed by the European Patent Office at 102 and Japan at 64; the WIPO/PCT route accounts for 54 filings, with Australia and the United Kingdom each under 20. This concentration suggests the US and Europe carry the deepest prior art and the most contested claim space, while jurisdictions like the UK and Australia have comparatively thinner coverage and may offer more room for a regional filing strategy.
US20170178971A1, assigned to IMEC and filed in 2017, claims a specific method of forming a III-V channel layer on silicon by depositing and later replacing a sacrificial dummy layer through etched via-holes using selective area growth. It blocks that particular dummy-layer-replacement sequence but does not cover III-V-on-silicon integration generally; direct epitaxial growth or wafer-bonding approaches, such as the silicon/III-V bonding method that is among the most-cited records in this space, sit outside its scope. Anyone building a CMOS device with a stacked III-V channel should check their process flow against this specific mechanism rather than assuming broader coverage.
Research Compound Semiconductor Manufacturing Process in depth with Eureka
Go past this page: query the whole compound semiconductor manufacturing process corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.